CD4 and melanoma: Furthermore, we showed that B220+ cell depletion but not asialo-GM1+ cell depletion was similar to the depletion of NK1.1+ cells, suggesting that B220+NK1.1+ pre-mNK cells were playing a role in dampening the CD4+ anti-tumor response in our preclinical model of melanoma [11].